Pelthos Therapeutics Inc. (PTHS) Stock
Pelthos Therapeutics stock price chart
PTHS stock quote & key statistics
Pelthos Therapeutics annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $16.8M | -$43.3M | -$16.58 |
| FY2024 | $0 | -$8.0M | -$11.82 |
| FY2023 | $0 | -$7.4M | — |
| FY2022 | $0 | -$2.5M | — |
| FY2021 | $0 | -$595,387 | — |
Fiscal year ending December 31. Source: company filings via EODHD.
About Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older.
It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Pelthos Therapeutics stock FAQ
What is the Pelthos Therapeutics stock ticker symbol?
Pelthos Therapeutics Inc. trades on the NYSE American under the ticker symbol PTHS.
What sector and industry is Pelthos Therapeutics in?
Pelthos Therapeutics Inc. is classified in the Healthcare sector, Biotechnology industry.
How many employees does Pelthos Therapeutics have?
Pelthos Therapeutics Inc. has about 92 full-time employees.
What were Pelthos Therapeutics's revenue and earnings last fiscal year?
Pelthos Therapeutics reported revenue of $16.8M and net income of -$43.3M in fiscal 2025, with earnings per share of -$16.58.
When did Pelthos Therapeutics go public?
Pelthos Therapeutics stock began trading on February 16, 2024.
Biotechnology stocks
All Healthcare stocks →- ACADACADIA Pharmaceuticals
- ALNYAlnylam
- ARWRArrowhead Pharmaceuticals
- ASNDAscendis Pharma A/S
- BMRNBioMarin Pharmaceutical
- CAICaris Life Sciences
- CORTCorcept Therapeutics
- EXELExelixis
- FTREFortrea
- HALOHalozyme Therapeutics
- HRMYHarmony Biosciences
- INCYIncyte
- IONSIonis Pharmaceuticals
- JAZZJazz Pharmaceuticals
- MDGLMadrigal Pharmaceuticals
- MRNAModerna
- NVAXNovavax
- PTCTPTC Therapeutics
- RAREUltragenyx Pharmaceutical
- REGNRegeneron
- RPRXRoyalty Pharma
- SRPTSarepta Therapeutics
- TECHBio-Techne
- VRTXVertex